| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| JENNISON ASSOCIATES LLC | 10.2% | +6% | $231M | $16.8M | 12.3M | +7.86% | Jennison Associates LLC | Sep 30, 2025 |
| PRUDENTIAL FINANCIAL INC | 10.1% | $159M | 12M | PRUDENTIAL FINANCIAL INC | Mar 31, 2025 | |||
| Frazier Life Sciences VIII, L.P. | 7.5% | $142M | 8.94M | Patrick J. Heron | Aug 18, 2025 | |||
| Polar Capital Holdings Plc | 4.2% | -24.2% | $79.3M | -$26.9M | 5.01M | -25.3% | Polar Capital Holdings Plc | Jun 30, 2025 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Change | Price | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 126M | $2.37B | -$12.8M | $18.85 | 232 |
| 2025 Q2 | 127M | $1.78B | +$21.6M | $14.02 | 228 |
| 2025 Q1 | 125M | $1.95B | -$63.3M | $15.64 | 238 |
| 2024 Q4 | 129M | $1.79B | +$16.1M | $13.93 | 205 |
| 2024 Q3 | 128M | $1.2B | +$14.2M | $9.30 | 187 |
| 2024 Q2 | 127M | $1.18B | +$21M | $9.30 | 185 |
| 2024 Q1 | 109M | $1.08B | +$267M | $9.91 | 125 |
| 2023 Q4 | 159K | $515K | -$27.2K | $3.23 | 3 |
| 2023 Q3 | 67.1M | $356M | -$30M | $5.31 | 132 |
| 2023 Q2 | 71.7M | $683M | -$6.79M | $9.53 | 132 |
| 2023 Q1 | 71.6M | $787M | +$44.3M | $11.00 | 139 |
| 2022 Q4 | 65.6M | $971M | +$88.1M | $14.80 | 136 |
| 2022 Q3 | 59.3M | $1.13B | +$194M | $19.11 | 135 |
| 2022 Q2 | 49.1M | $1.05B | +$17.6M | $21.31 | 110 |
| 2022 Q1 | 48.2M | $927M | +$37.2M | $19.26 | 103 |
| 2021 Q4 | 45.7M | $948M | -$2.87M | $20.74 | 86 |
| 2021 Q3 | 45.7M | $1.09B | +$4.2M | $23.89 | 100 |
| 2021 Q2 | 45.4M | $1.24B | -$38M | $27.29 | 99 |
| 2021 Q1 | 46.8M | $1.35B | +$171M | $28.93 | 91 |
| 2020 Q4 | 40.8M | $1.15B | +$134M | $28.13 | 77 |
| 2020 Q3 | 34.8M | $1.02B | +$28.9M | $29.30 | 60 |
| 2020 Q2 | 33.8M | $1.02B | +$33.1M | $30.24 | 55 |
| 2020 Q1 | 32.7M | $974M | +$973M | $29.80 | 48 |